| 12098148 |
Therapeutic compounds |
Emma Louise Blaney, Duncan J. Crick, Simon Ross Crumpler, George Hynd, Cathy Louise Lucas +9 more |
2024-09-24 |
| 12024509 |
Therapeutic compounds as inhibitors of the orexin-1 receptor |
Emma Louise Blaney, Barrie Martin, Martin John Watson |
2024-07-02 |
| 10611760 |
Therapeutic compounds as inhibitors of the orexin-1 receptor |
Emma Louise Blaney, Barrie Martin, Martin John Watson |
2020-04-07 |
| 7799781 |
5,6,7,8-tetrahydropteridine derivatives as HSP90 inhibitors |
— |
2010-09-21 |
| 7795283 |
Oxadiazole derivative as DGAT inhibitors |
Alan Martin Birch, Suzanne Saxon Bowker, Roger John Butlin, Craig Samuel Donald, William McCoull +1 more |
2010-09-14 |
| 7579349 |
4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer |
Andrew Peter Thomas |
2009-08-25 |
| 6960688 |
Use of compounds for the elevation of pyruvate dehydrogenase activity |
Roger John Butlin, Jeremy Burrows, Michael Howard Block |
2005-11-01 |
| 6878712 |
Amides as inhibitors for pyruvate dehydrogenase |
Roger John Butlin, Janet Elizabeth Pease, Michael Howard Block, Jeremy Burrows, David Stephen Clarke |
2005-04-12 |
| 6689909 |
Substituted N-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
Roger John Butlin, Janet Elizabeth Pease, Michael Howard Block, Jeremy Burrows |
2004-02-10 |
| 6667342 |
Benzenesulfonamide-derivatives and their use as medicaments |
David Stephen Clarke, Jeremy Burrows, Paul Ro Whittamore, Roger John Butlin |
2003-12-23 |
| 6552225 |
Chemical compounds |
Roger John Butlin, Janet Elizabeth Pease, Michael Howard Block, Jeremy Burrows |
2003-04-22 |
| 6498275 |
Use of compounds for the elevation of pyruvate dehydrogenase activity |
Roger John Butlin, Jeremy Burrows, Michael Howard Block |
2002-12-24 |
| 6458793 |
Heterocyclic derivatives which inhibit factor Xa |
Peter Warner, Roger James |
2002-10-01 |